Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in the Golden Syrian hamster causes lung pathology that resembles human coronavirus disease (COVID-19). However, extrapulmonary pathologies associated with SARS-CoV-2 infection and post-COVID sequelae remain to be understood. Her...

Full description

Bibliographic Details
Main Authors: Zaigham Abbas Rizvi, Rajdeep Dalal, Srikanth Sadhu, Akshay Binayke, Jyotsna Dandotiya, Yashwant Kumar, Tripti Shrivastava, Sonu Kumar Gupta, Suruchi Aggarwal, Manas Ranjan Tripathy, Deepak Kumar Rathore, Amit Kumar Yadav, Guruprasad R Medigeshi, Amit Kumar Pandey, Sweety Samal, Shailendra Asthana, Amit Awasthi
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2022-01-01
Series:eLife
Subjects:
Online Access:https://elifesciences.org/articles/73522
_version_ 1811199407189655552
author Zaigham Abbas Rizvi
Rajdeep Dalal
Srikanth Sadhu
Akshay Binayke
Jyotsna Dandotiya
Yashwant Kumar
Tripti Shrivastava
Sonu Kumar Gupta
Suruchi Aggarwal
Manas Ranjan Tripathy
Deepak Kumar Rathore
Amit Kumar Yadav
Guruprasad R Medigeshi
Amit Kumar Pandey
Sweety Samal
Shailendra Asthana
Amit Awasthi
author_facet Zaigham Abbas Rizvi
Rajdeep Dalal
Srikanth Sadhu
Akshay Binayke
Jyotsna Dandotiya
Yashwant Kumar
Tripti Shrivastava
Sonu Kumar Gupta
Suruchi Aggarwal
Manas Ranjan Tripathy
Deepak Kumar Rathore
Amit Kumar Yadav
Guruprasad R Medigeshi
Amit Kumar Pandey
Sweety Samal
Shailendra Asthana
Amit Awasthi
author_sort Zaigham Abbas Rizvi
collection DOAJ
description Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in the Golden Syrian hamster causes lung pathology that resembles human coronavirus disease (COVID-19). However, extrapulmonary pathologies associated with SARS-CoV-2 infection and post-COVID sequelae remain to be understood. Here, we show, using a hamster model, that the early phase of SARS-CoV-2 infection leads to an acute inflammatory response and lung pathologies, while the late phase of infection causes cardiovascular complications (CVCs) characterized by ventricular wall thickening associated with increased ventricular mass/body mass ratio and interstitial coronary fibrosis. Molecular profiling further substantiated our findings of CVC as SARS-CoV-2-infected hamsters showed elevated levels of serum cardiac troponin I, cholesterol, low-density lipoprotein, and long-chain fatty acid triglycerides. Serum metabolomics profiling of SARS-CoV-2-infected hamsters identified N-acetylneuraminate, a functional metabolite found to be associated with CVC, as a metabolic marker was found to be common between SARS-CoV-2-infected hamsters and COVID-19 patients. Together, we propose hamsters as a suitable animal model to study post-COVID sequelae associated with CVC, which could be extended to therapeutic interventions.
first_indexed 2024-04-12T01:48:25Z
format Article
id doaj.art-78b2b9d894bf4efaab700a2327c7617c
institution Directory Open Access Journal
issn 2050-084X
language English
last_indexed 2024-04-12T01:48:25Z
publishDate 2022-01-01
publisher eLife Sciences Publications Ltd
record_format Article
series eLife
spelling doaj.art-78b2b9d894bf4efaab700a2327c7617c2022-12-22T03:53:01ZengeLife Sciences Publications LtdeLife2050-084X2022-01-011110.7554/eLife.73522Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infectionZaigham Abbas Rizvi0https://orcid.org/0000-0001-7850-5672Rajdeep Dalal1Srikanth Sadhu2Akshay Binayke3https://orcid.org/0000-0002-9808-9036Jyotsna Dandotiya4Yashwant Kumar5Tripti Shrivastava6Sonu Kumar Gupta7Suruchi Aggarwal8Manas Ranjan Tripathy9Deepak Kumar Rathore10Amit Kumar Yadav11https://orcid.org/0000-0002-9445-8156Guruprasad R Medigeshi12Amit Kumar Pandey13Sweety Samal14Shailendra Asthana15Amit Awasthi16https://orcid.org/0000-0002-2563-1971Immuno-biology Lab, Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India; Immunology Core, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, IndiaImmuno-biology Lab, Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, IndiaImmuno-biology Lab, Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, IndiaImmuno-biology Lab, Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, IndiaImmuno-biology Lab, Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, IndiaNon-communicable Disease Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, IndiaInfection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, IndiaNon-communicable Disease Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, IndiaNon-communicable Disease Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, IndiaImmuno-biology Lab, Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, IndiaInfection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, IndiaNon-communicable Disease Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, IndiaInfection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, IndiaInfection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, IndiaInfection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, IndiaNon-communicable Disease Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, IndiaImmuno-biology Lab, Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India; Immunology Core, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, IndiaSevere acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in the Golden Syrian hamster causes lung pathology that resembles human coronavirus disease (COVID-19). However, extrapulmonary pathologies associated with SARS-CoV-2 infection and post-COVID sequelae remain to be understood. Here, we show, using a hamster model, that the early phase of SARS-CoV-2 infection leads to an acute inflammatory response and lung pathologies, while the late phase of infection causes cardiovascular complications (CVCs) characterized by ventricular wall thickening associated with increased ventricular mass/body mass ratio and interstitial coronary fibrosis. Molecular profiling further substantiated our findings of CVC as SARS-CoV-2-infected hamsters showed elevated levels of serum cardiac troponin I, cholesterol, low-density lipoprotein, and long-chain fatty acid triglycerides. Serum metabolomics profiling of SARS-CoV-2-infected hamsters identified N-acetylneuraminate, a functional metabolite found to be associated with CVC, as a metabolic marker was found to be common between SARS-CoV-2-infected hamsters and COVID-19 patients. Together, we propose hamsters as a suitable animal model to study post-COVID sequelae associated with CVC, which could be extended to therapeutic interventions.https://elifesciences.org/articles/73522hamsterSARS-CoV2cardiovascular
spellingShingle Zaigham Abbas Rizvi
Rajdeep Dalal
Srikanth Sadhu
Akshay Binayke
Jyotsna Dandotiya
Yashwant Kumar
Tripti Shrivastava
Sonu Kumar Gupta
Suruchi Aggarwal
Manas Ranjan Tripathy
Deepak Kumar Rathore
Amit Kumar Yadav
Guruprasad R Medigeshi
Amit Kumar Pandey
Sweety Samal
Shailendra Asthana
Amit Awasthi
Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection
eLife
hamster
SARS-CoV2
cardiovascular
title Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection
title_full Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection
title_fullStr Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection
title_full_unstemmed Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection
title_short Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection
title_sort golden syrian hamster as a model to study cardiovascular complications associated with sars cov 2 infection
topic hamster
SARS-CoV2
cardiovascular
url https://elifesciences.org/articles/73522
work_keys_str_mv AT zaighamabbasrizvi goldensyrianhamsterasamodeltostudycardiovascularcomplicationsassociatedwithsarscov2infection
AT rajdeepdalal goldensyrianhamsterasamodeltostudycardiovascularcomplicationsassociatedwithsarscov2infection
AT srikanthsadhu goldensyrianhamsterasamodeltostudycardiovascularcomplicationsassociatedwithsarscov2infection
AT akshaybinayke goldensyrianhamsterasamodeltostudycardiovascularcomplicationsassociatedwithsarscov2infection
AT jyotsnadandotiya goldensyrianhamsterasamodeltostudycardiovascularcomplicationsassociatedwithsarscov2infection
AT yashwantkumar goldensyrianhamsterasamodeltostudycardiovascularcomplicationsassociatedwithsarscov2infection
AT triptishrivastava goldensyrianhamsterasamodeltostudycardiovascularcomplicationsassociatedwithsarscov2infection
AT sonukumargupta goldensyrianhamsterasamodeltostudycardiovascularcomplicationsassociatedwithsarscov2infection
AT suruchiaggarwal goldensyrianhamsterasamodeltostudycardiovascularcomplicationsassociatedwithsarscov2infection
AT manasranjantripathy goldensyrianhamsterasamodeltostudycardiovascularcomplicationsassociatedwithsarscov2infection
AT deepakkumarrathore goldensyrianhamsterasamodeltostudycardiovascularcomplicationsassociatedwithsarscov2infection
AT amitkumaryadav goldensyrianhamsterasamodeltostudycardiovascularcomplicationsassociatedwithsarscov2infection
AT guruprasadrmedigeshi goldensyrianhamsterasamodeltostudycardiovascularcomplicationsassociatedwithsarscov2infection
AT amitkumarpandey goldensyrianhamsterasamodeltostudycardiovascularcomplicationsassociatedwithsarscov2infection
AT sweetysamal goldensyrianhamsterasamodeltostudycardiovascularcomplicationsassociatedwithsarscov2infection
AT shailendraasthana goldensyrianhamsterasamodeltostudycardiovascularcomplicationsassociatedwithsarscov2infection
AT amitawasthi goldensyrianhamsterasamodeltostudycardiovascularcomplicationsassociatedwithsarscov2infection